Dortmund, Germany

Jens Bitzer

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Jens Bitzer: A Pioneer in Glycolipid Research

Introduction

Jens Bitzer is an accomplished inventor based in Dortmund, Germany. With a total of five patents to his name, Bitzer is recognized for his significant contributions to the field of glycolipid compounds. His innovative work focuses on developing solutions for preserving materials and preventing microbial contamination.

Latest Patents

Among his latest patents, the most notable invention involves long chain glycolipids that demonstrate preservative and antimicrobial properties. This invention specifically pertains to the use of certain glycolipid compounds, characterized by a detailed formula. The compounds hold the potential to be utilized in open chain form and may also exist as lactones. These novel compounds aim to improve material preservation and enhance safety by avoiding microbial contamination.

Career Highlights

Throughout his career, Jens Bitzer has made significant strides in his field. He has worked with several esteemed organizations, including Imd Natural Solutions GmbH and Prairie Berry Europe GmbH. His role in these companies has been pivotal in advancing research and development in glycolipid technologies.

Collaborations

Bitzer has been fortunate to collaborate with talented individuals such as Bärbel Köpcke and Marc Stadler. These partnerships have facilitated the exchange of ideas and expertise, furthering the innovations in which Bitzer has played a crucial role.

Conclusion

Jens Bitzer stands out as a leading inventor in the realm of glycolipid research. His five patents reflect his dedication to creating effective solutions for material preservation. With each innovative leap, Bitzer continues to make a significant impact in the industry and pave the way for future advancements in antimicrobial technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…